Search results
- 164.45Add to watchlist+0.61 (+0.37%)As of Fri. Jul 5, 2024 10:31 AM EDT · Nasdaq Real Time Price (USD) · Market open
- Open166.09High164.92Low163.63
- Mkt Cap290.4BP/E (TTM)48.94Div & Yield6.20 & 3.74%
- Prev. Close163.8452 Wk. Low132.7052 Wk. High182.89
What analysts are sayingTop storiesAbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded UseYahoo Finance · 4 days ago- ABBV +0.37%
With 72% ownership, AbbVie Inc. (NYSE:ABBV) boasts of strong institutional backingYahoo Finance · 3 days agoAbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD PresenceYahoo Finance · 1 week agoRelated stocks
3 days ago · Should You Buy or Sell AbbVie Stock? Get The Latest ABBV Stock Analysis, Price Target, Dividend Info, Headlines, and Short Interest at MarketBeat.
3 days ago · Get the latest AbbVie Inc ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
6 days ago · The latest AbbVie stock prices, stock quotes, news, and ABBV history to help you invest and trade smarter.
Jun 26, 2023 · View AbbVie, Inc. ABBV stock quote prices, financial information, real-time forecasts, and company news from CNN.
3 days ago · ABBV's current price target is $179.64. Learn why top analysts are making this stock forecast for AbbVie at MarketBeat.
3 days ago · AbbVie is not owned by hedge funds. The company's largest shareholder is The Vanguard Group, Inc., with ownership of 9.6%. BlackRock, Inc. is the second largest shareholder owning 8.1% of common ...
Jun 27, 2024 · Even though AbbVie's stock has been a strong performer, the company's shares only trade at 15.2 times forward earnings. That's a significant discount, compared to the 22.6 multiple of the S&P 500.